Late-onset cerebral toxoplasmosis after allogeneic bone marrow transplantation
Toxoplasmosis after bone marrow transplantation (BMT) is diagnosed infrequently. In a recent review, 55 reported cases were identified; 51 were associated with allogeneic BMT, three with autologous BMT, and one with syngeneic BMT. 1 Most of the infections occurred in seropositive patients, a finding suggesting reactivation of latent infection. In most of the patients, the diagnosis was made at autopsy, and the most frequently involved organs were the brain, heart and lungs. Not surprisingly, patients with graftversus-host disease (GVHD) who were receiving immunosuppressive therapy were at a higher risk, and prophylaxis for Pneumocystis carinii pneumonia with trimethoprimsulfamethoxazole was not always adequate to prevent toxoplasmosis. 2 An antemortem pathologic diagnosis of central nervous system (CNS) toxoplasmosis in patients who have had BMT is seldom made, and delayed disease presentation is unusual. 2, 3 Computed tomography of the brain does not always reveal the pathologic lesions, and magnetic resonance imaging may be more sensitive. 2, 4, 5 We describe a patient who had undergone allogeneic BMT who presented with characteristic neurologic features of cerebral toxoplasmosis but delayed onset of disease. The diagnosis was supported by consistent abnormalities on magnetic resonance imaging and biopsy-proven evidence of infection.
A 50-year-old woman with severe graft-versus-host disease presented with lethargy and right hemichorea 1 year after allogeneic BMT for chronic myelogenous leukemia. At the time, the patient was receiving chronic cyclosporine and corticosteroid therapy, and because of an allergy to sulfonamides she was not receiving trimethoprim-sulfamethoxazole as prophylaxis for Pneumocystis carinii pneumonia. Gadolinium-enhanced axial magnetic resonance imaging of the head revealed multiple, bilateral, superficial and deep, homogeneously and densely enhancing mass lesions, without corresponding mass effect (Figure 1 ). The scan in the context of the patient's underlying chronic myelogenous leukemia and her GVHD-and therapy-related immunocompromised state led to a short differential diagnosis, including opportunistic infection, inflammatory demyelination, CNS lymphoma and leukemic infiltration. A magnetic resonance-guided stereotactic brain biopsy of the left frontal lesion led to the diagnosis of cerebral toxoplasmosis. Pretransplant serologic results for Toxoplasma were not available. Despite significant improvement in the magnetic resonance scan, 10 months of therapy with pyrimethamine and clindamycin has not affected the hemichorea.
The reported clinical presentation of post-BMT CNS toxoplasmosis has included confusion, seizures and hemiparesis. 2, 3 Our patient presented with hemichoreoathetosis, a feature found in approximately 6% of patients with the acquired immunodeficiency syndrome (AIDS) and cerebral tox- oplasmosis. 6 Unlike the result in patients with AIDS, treatment did not improve the movement disorder in our patient.
Opportunistic infections involving the CNS in immunocompromised patients may involve the leptomeninges, 7 the brain parenchyma, or both. In encephalitis, the location of the lesion(s) may suggest a particular causative organism. For example, neuron-to-neuron transmission from the nasopharynx is thought to explain the predilection of herpes simplex virus for the anterior temporal lobe. Toxoplasmosis, however, has a predilection for the basal ganglia, although the exact mechanism of this is unknown. 5 In previously reported cases of cerebral toxoplasmosis after allogeneic BMT, cranial computed tomography has shown ring-enhancing lesions in the frontal lobe, whereas magnetic resonance imaging may be more sensitive for demonstrating lesions undetectable by computed tomography. 2, 5 Progressive multifocal leukoencephalopathy is a white matter disease found in immunosuppressed patients with leukemia and lymphoma. The imaging abnormalities consist of multiple confluent areas of abnormal white matter signal, free of contrast enhancement and mass effect. Furthermore, the disease usually begins in the parieto-occipital white matter and spreads forward. The intensity of contrast enhancement and the distribution of lesions in our patient virtually exclude progressive multifocal leukoencephalopathy as a diagnosis.
CNS lymphoma can affect leptomeninges and brain parenchyma simultaneously. In our patient, the magnetic resonance scan was similar to that in patients with primary CNS lymphoma, in the context of human immunodeficiency virus and the post-transplant lymphoproliferative disorders. In these patients, multiple lesions are common, and some may have a variable contrast enhancement. 5 In contrast, direct involvement of the brain parenchyma by leukemia is uncommon and typically occurs as a chloroma or as isolated leukemic nodules.
A high clinical suspicion augmented by sensitive radiologic studies and the use of stereotactic brain biopsy should facilitate early diagnosis of CNS toxoplasmosis, enable timely treatment, and avoid potentially toxic empiric therapy. 8 The recent application of polymerase chain reaction to amplify Toxoplasma DNA may enhance the diagnostic process further. 9 Although prophylactic antibiotics reduce the risk in seropositive patients, the infrequent occurrence of the disease does not warrant uniform application to all patients. 
Influence of bacterial endotoxin on the allogenicity of human endothelial cells
In former times the endothelium has been judged as a simple barrier between the blood and surrounding tissues. However, data from the last decade provide accumulating evidence that there is a close interaction between immunological effector cells and the vasculature in various physiological and inflammatory processes. In particular, endothelial cells (EC) have been identified as allogeneic targets for proliferative immune responses 1 as well as for cytotoxic T lymphocytes. 2 In addition, allogeneic monocytes were found to induce apoptosis in EC through the action of transmembrane TNF-␣. 3, 4 These cytotoxic mechanisms may contribute to the pathophysiology of various complications following BMT that are associated with EC damage or malfunction. 5 There is increasing evidence that pretransplant conditioning regimens, including total body irradiation and cytotoxic chemotherapy, may contribute to an activation of the recipients' endothelium resulting in early inflammatory processes, 6 for example, through the increased expression of adhesion molecules and MHC complexes. Also, the conditioning-mediated influx of bacterial toxins like lipopolysaccharide (LPS) across damaged mucosal barriers can cre- ate an immunologically activated state. Therefore, it was interesting to investigate whether LPS (Sigma, Deisenhofen, Germany) might influence the allogenicity of human vascular endothelial cells. Allogeneic peripheral blood mononuclear cells (PBMC) of a healthy human volunteer were adherence selected twice according to a previously published protocol, 7 in order to deplete monocytes and the majority of natural killer (NK) cells. Subsequently, nonadherent lymphocytes were stimulated for 7 days with lethally
